Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S100B Protein in Minor Traumatic Brain Injury Patients on Antiplatelet Therapy
NCT03780062Phase 3Completed
- Sponsor
- CHU de Poitiers
- Start
- Jan 2019
- Primary completion
- Apr 2025
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial, sponsored by CHU de Poitiers. Primary endpoint: Brain scanner Detection of a cerebral lesion requiring a surgery or medical intervention or an hospitalisation at 3 hours. Started Jan 2019; status: completed.
Beyond the preview
Go deeper on NCT03780062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03780062.